Promising Results in CAR NK Cell Therapy for B-Cell Malignancies
A Phase I/II trial conducted by researchers from The University of Texas MD Anderson Cancer Center has shown promising results in patients with relapsed or …
Unleashing Industry Insights, Connecting the Future
A Phase I/II trial conducted by researchers from The University of Texas MD Anderson Cancer Center has shown promising results in patients with relapsed or …